2022
DOI: 10.1016/j.cossms.2022.101031
|View full text |Cite
|
Sign up to set email alerts
|

Preparation and applications of artificial mucins in biomedicine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
10
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(10 citation statements)
references
References 129 publications
0
10
0
Order By: Relevance
“…Aberrant mucin production is associated with a variety of human pathologies from dry eyes and cystic fibrosis to cancer and infection . Mucins are needed in research models of disease and as therapeutics for lubrication, vaccines, antivirals/antimicrobials, and medical device coatings. However, development of such models and therapies has been challenged by inherent heterogeneity in mucin structure and limited access to human samples. , An additional challenge is that mucins can be rapidly degraded, which particularly limits therapeutic applications. Therefore, artificial mucins are an area of emerging research. , Here, we report the synthesis and evaluation of artificial mucins that are structural and chemical analogues of native mucins, bind protein targets via their glycans, and have biodegradation rates that can be finely tuned.…”
Section: Introductionmentioning
confidence: 97%
See 4 more Smart Citations
“…Aberrant mucin production is associated with a variety of human pathologies from dry eyes and cystic fibrosis to cancer and infection . Mucins are needed in research models of disease and as therapeutics for lubrication, vaccines, antivirals/antimicrobials, and medical device coatings. However, development of such models and therapies has been challenged by inherent heterogeneity in mucin structure and limited access to human samples. , An additional challenge is that mucins can be rapidly degraded, which particularly limits therapeutic applications. Therefore, artificial mucins are an area of emerging research. , Here, we report the synthesis and evaluation of artificial mucins that are structural and chemical analogues of native mucins, bind protein targets via their glycans, and have biodegradation rates that can be finely tuned.…”
Section: Introductionmentioning
confidence: 97%
“…3−7 However, development of such models and therapies has been challenged by inherent heterogeneity in mucin structure and limited access to human samples. 4,8 An additional challenge is that mucins can be rapidly degraded, which particularly limits therapeutic applications. 9−11 Therefore, artificial mucins are an area of emerging research.…”
Section: ■ Introductionmentioning
confidence: 99%
See 3 more Smart Citations